Jantoven

Indicated For

Atrial Fibrillation (AF), Venous Thromboembolism (VTE)

About This Medication

# Upsher-Smith Promise of Support Program Patient Guide: How to Get Jantoven (warfarin) at Low or No Cost Jantoven (warfarin sodium tablets) is a prescription anticoagulant medication manufactured by Upsher-Smith Laboratories, used to prevent and treat blood clots in conditions like atrial fibrillation, deep vein thrombosis, and pulmonary embolism. The **Upsher-Smith Promise of Support Program** provides free or low-cost access to Jantoven for eligible patients who cannot afford their medication, particularly those who are uninsured or underinsured.[1][8] ## About Jantoven (warfarin) **Jantoven** is the generic equivalent of Coumadin, available in tablet strengths of 1 mg (pink), 2 mg (lavender), and others up to 10 mg. It works by inhibiting vitamin K-dependent clotting factors in the blood, helping to prevent harmful clots from forming or growing larger. Your doctor will prescribe it based on your specific condition, and you'll need regular blood tests (INR monitoring) to ensure safe dosing, as warfarin has a narrow therapeutic range and interacts with many foods, drugs, and supplements.[6] Common uses include: - Preventing strokes in patients with atrial fibrillation. - Treating and preventing deep vein thrombosis (DVT) and pulmonary embolism (PE). - Preventing clots after heart valve replacement or certain surgeries. **Important safety note**: Warfarin carries a boxed warning for bleeding risk. Always follow your doctor's instructions, report unusual bleeding or bruising, and maintain consistent vitamin K intake from foods like leafy greens. ## Who Qualifies for the Program? The **Promise of Support Program** is designed for patients facing financial hardship who lack adequate insurance coverage. It offers free medication to the uninsured and bridge or copay assistance for the underinsured. Specific income thresholds are not publicly detailed, but programs like this typically target those at or below 400-500% of the Federal Poverty Level (FPL). Contact Upsher-Smith to confirm eligibility based on your household size and income.[1][8] Eligibility generally requires: - U.S. residency. - Prescription for Jantoven from a licensed physician. - Proof of financial need (e.g., income documentation). - Limited or no prescription insurance coverage. Physicians are limited to enrolling about 5 patients per month, so early application is key.[2] ## Income Eligibility Breakdown Detailed income limits are not specified in available program resources, which is common for manufacturer programs requiring case-by-case review. Here's a general guide based on similar patient assistance programs (PAPs). Always verify with Upsher-Smith at 1-800-654-2299, as eligibility may adjust annually.[10] | Household Size | Estimated Max Annual Income (400% FPL, 2026) | Notes | |----------------|---------------------------------------------|-------| | 1 (Individual) | ~$60,000 | Approximate; subject to program rules. | | 2 (Couple) | ~$81,000 | Includes dependents. | | 3 | ~$102,000 | Case-by-case review. | | 4 | ~$123,000 | Higher for larger families. | *These are illustrative based on U.S. FPL guidelines; actual thresholds may vary. Programs often exclude high-income individuals with insurance.*[1][2] ## Insurance Requirements The program primarily serves **uninsured patients** with free medication. For **underinsured** (e.g., those with high-deductible plans or Medicare), bridge programs and copay assistance may apply, but patients with government insurance like Medicare Part D may have restrictions. Commercially insured patients might access copay cards through related programs like Access Pathways, but confirm Jantoven applicability. Do not enroll if you have active third-party coverage that fully pays for the drug.[1][5][8] ## Step-by-Step Application Process 1. **Discuss with your doctor**: Confirm Jantoven is appropriate and ask them to initiate enrollment. Physicians complete and submit applications (new one required per order).[2] 2. **Gather documents**: Prepare proof of income (tax returns, pay stubs, W-2s), proof of residency, prescription, and insurance status (or lack thereof). No full list is specified, but these are standard.[1] 3. **Contact Upsher-Smith**: Call **1-800-654-2299** (Monday-Friday, business hours) or visit their website to start. Your doctor may need to fax or mail the application.[10] 4. **Submit application**: Doctor submits on your behalf. Limited to 5 patients per doctor per month.[2] 5. **Wait for approval**: Processing time varies; expect 1-4 weeks typically for PAPs. 6. **Receive medication**: Shipped directly to your doctor or pharmacy for pickup/delivery.[1] ## Timeline and Delivery - **Approval timeline**: 1-4 weeks after submission, though urgent bridge supplies may be faster via specialty partners.[3][4] - **Supply duration**: Often 1-3 months per approval; new application needed for refills.[2] - **Delivery**: Medication is typically sent to your healthcare provider's office or a designated pharmacy. Free home delivery may be available through partnered pharmacies for some programs.[4][5] Track status by calling the program phone number. ## Alternatives if Denied or Ineligible - **Other PAPs**: Search RxAssist.org or RxHope.com for warfarin generics from other manufacturers.[1][2] - **State programs**: Check your state's pharmaceutical assistance for low-income seniors. - **Coupons/savings cards**: GoodRx or SingleCare for discounts (up to 80% off). - **Medicaid/Medicare Extra Help**: Apply via SSA.gov if low-income. - **Samples**: Informal doctor samples via Upsher-Smith reps.[7] - **Generic options**: Jantoven is already a low-cost generic; shop pharmacies. ## Reauthorization and Refills Reauthorization is required periodically (e.g., every 3-12 months). Submit a new application for each order. Your doctor handles refill requests.[2] ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Program details can change; always contact Upsher-Smith directly at 1-800-654-2299 for the latest information. This is not medical advice—consult your healthcare provider for treatment decisions. Eligibility not guaranteed. Upsher-Smith reserves the right to modify or end the program.[1][2][10] (Word count: 1028)

Program information last verified: March 30, 2026